Next-Generation Probiotics (NGPs) are beneficial bacteria that are developed for pharmaceutical application and have been shown to target specific diseases. Due to the rapid development of advanced genetic sequencing tools and the bioinformatics platforms, as well as more powerful tools to edit and modify bacterial genomes, increasing interests have been devoted to the evaluation of new strains of probiotics and applicability in biomedical research.
Based on our expertise in microbiota and microbiome science, Creative Biolabs is focused on providing full range of live biotherapeutics drug discovery services, including strain identification and validation, analytical development and qualification, manufacturing, cell bank creation and storage, fermentation, lyophilization, etc. Our product portfolio extends from aerobic bacteria to anaerobic bacteria, depending on your research-tailored demands.